The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved on Thursday the use of the Moderna COVID-19 vaccine Spikevax for children ages 6 to 11
MOSCOW (Pakistan Point News / Sputnik - 14th April, 2022) The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved on Thursday the use of the Moderna COVID-19 vaccine Spikevax for children ages 6 to 11.
"I am pleased to confirm that that the COVID-19 vaccine made by Moderna, 'Spikevax', has now been authorised in Great Britain in 6 to 11 year olds. The vaccine is safe and effective in this age group," MHRA head June Raine said in a statement.
In January 2021, the Spikevax vaccine was authorized for adults over 18, and in August 2021 it was approved for those ages 12-17, according to the statement.
The UK has approved six vaccines against the coronavirus, including those produced by BioNTech/Pfizer, Johnson & Johnson, Moderna, Novavax, Astrazeneca and Valneva. The latter vaccine, developed by the French pharmaceutical company Valneva, was approved earlier in the day, making the UK the first country to use it.
